several prescription bottles filled with colorfu pills and capsules, shot from above on white background with soft white drop shadow

According to an article via, “Revenue from important new medicines for various cancers, hepatitis C and more helped top U.S. drugmakers weather unfavorable currency exchange rates and other challenges. Pfizer Inc., Merck & Co. and Bristol-Myers Squibb Co., which reported first-quarter results Tuesday, all derive at least half their revenue from selling products overseas. Because they’re purchased in local currencies, the strong dollar is depressing the sales’ value.”  For more information on these highlights, please visit: